These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 7747153)

  • 21. Mechanism of stone formation.
    Mandel N
    Semin Nephrol; 1996 Sep; 16(5):364-74. PubMed ID: 8890393
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Current concepts on the pathogenesis of urinary stones].
    Mager R; Neisius A
    Urologe A; 2019 Nov; 58(11):1272-1280. PubMed ID: 31432240
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of inositol hexaphosphate (phytate) on calcium binding, calcium oxalate crystallization and in vitro stone growth.
    Saw NK; Chow K; Rao PN; Kavanagh JP
    J Urol; 2007 Jun; 177(6):2366-70. PubMed ID: 17509360
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Uronic-acid-rich protein: a new glycoprotein inhibiting the crystallization of calcium oxalate in vitro].
    Atmani F; Lacour B; Daudon M
    Nephrologie; 1996; 17(3):157-62. PubMed ID: 9064564
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Role of urinary bikunin in the inhibition of calcium oxalate crystallization.
    Atmani F; Khan SR
    J Am Soc Nephrol; 1999 Nov; 10 Suppl 14():S385-8. PubMed ID: 10541269
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact of various modifiers on calcium oxalate crystallization.
    Kulaksizoglu S; Sofikerim M; Cevik C
    Int J Urol; 2007 Mar; 14(3):214-8. PubMed ID: 17430258
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Physicochemical considerations in the development and prevention of calcium oxalate urolithiasis.
    Kok DJ; Papapoulos SE
    Bone Miner; 1993 Jan; 20(1):1-15. PubMed ID: 8453319
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Crystallization inhibitors in the pathophysiology and treatment of nephrolithiasis.
    Marangella M; Bagnis C; Bruno M; Vitale C; Petrarulo M; Ramello A
    Urol Int; 2004; 72 Suppl 1():6-10. PubMed ID: 15133325
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Renal intratubular crystals and hyaluronan staining occur in stone formers with bypass surgery but not with idiopathic calcium oxalate stones.
    Evan AP; Coe FL; Gillen D; Lingeman JE; Bledsoe S; Worcester EM
    Anat Rec (Hoboken); 2008 Mar; 291(3):325-34. PubMed ID: 18286613
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Urinary glycosaminoglycans are selectively included into calcium oxalate crystals precipitated from whole human urine.
    Suzuki K; Mayne K; Doyle IR; Ryall RL
    Scanning Microsc; 1994; 8(3):523-30. PubMed ID: 7747154
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Effects of diuretic therapy on spontaneous expulsion of urinary calculi, urinary pH, and crystalluria in lithiasic patients].
    Kaid-Omar Z; Belouatek A; Driouch A; Taleb-Bendiab H; Lacour B; Addou A; Daudon M
    Prog Urol; 2001 Jun; 11(3):450-7. PubMed ID: 11512457
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Artificial simulation of renal stone formation. Influence of some urinary components.
    Grases F; Costa-Bauzá A; March JG; Söhnel O
    Nephron; 1993; 65(1):77-81. PubMed ID: 8413796
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Crystal agglomeration is a major element in calcium oxalate urinary stone formation.
    Kok DJ; Papapoulos SE; Bijvoet OL
    Kidney Int; 1990 Jan; 37(1):51-6. PubMed ID: 2299809
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Experimental technique simulating oxalocalcic renal stone generation.
    Söhnel O; Grases F; March JG
    Urol Res; 1993 Mar; 21(2):95-9. PubMed ID: 8503154
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of agglomeration in calcium oxalate monohydrate urolith development.
    Grases F; Millan A; Söhnel O
    Nephron; 1992; 61(2):145-50. PubMed ID: 1630537
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Calcium oxalate nephrolithiasis, a free or fixed particle disease.
    Kok DJ; Khan SR
    Kidney Int; 1994 Sep; 46(3):847-54. PubMed ID: 7996806
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Agglomeration of calcium oxalate monohydrate in synthetic urine.
    Grases F; Masárová L; Söhnel O; Costa-Bauzá A
    Br J Urol; 1992 Sep; 70(3):240-6. PubMed ID: 1422681
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Methods for measuring crystallization in urolithiasis research: why, how and when?
    Hess B; Ryall RL; Kavanagh JP; Khan SR; Kok DJ; Rodgers AL; Tiselius HG
    Eur Urol; 2001 Aug; 40(2):220-30. PubMed ID: 11528202
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A nidus, crystalluria and aggregation: key ingredients for stone enlargement.
    Saw NK; Rao PN; Kavanagh JP
    Urol Res; 2008 Feb; 36(1):11-5. PubMed ID: 18030459
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The role of the papilla in idiopathic calcium oxalate nephrolithiasis.
    Krautschick A; Esen T
    World J Urol; 1997; 15(4):213-8. PubMed ID: 9280049
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.